Page last updated: 2024-09-05

sb 203580 and Anasarca

sb 203580 has been researched along with Anasarca in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barreiro, EJ; Cunha, FQ; de Lima, CK; de Miranda, AL; de Oliveira Lopes, R; Lima, LM; Louback da Silva, L; Nascimento, PG; Romeiro, NC	1

Other Studies

1 other study(ies) available for sb 203580 and Anasarca

Article	Year
Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors. European journal of medicinal chemistry, 2012, Volume: 54 Topics: Animals; Carrageenan; Dose-Response Relationship, Drug; Drug Design; Edema; Female; Male; Mice; Molecular Docking Simulation; Nociception; p38 Mitogen-Activated Protein Kinases; Protein Conformation; Protein Kinase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Urea	2012

Article

Year

Docking, synthesis and pharmacological activity of novel urea-derivatives designed as p38 MAPK inhibitors.

European journal of medicinal chemistry, 2012, Volume: 54

Topics: Animals; Carrageenan; Dose-Response Relationship, Drug; Drug Design; Edema; Female; Male; Mice; Molecular Docking Simulation; Nociception; p38 Mitogen-Activated Protein Kinases; Protein Conformation; Protein Kinase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Urea

2012